BMNR vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BMNR exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating deteriorating financial health. While revenue growth is explosive at 627.8%, it is decoupled from profitability, as evidenced by a catastrophic operating margin of -592.09% and an astronomical Price-to-Sales ratio of 712.25. The stock has experienced a massive technical collapse from a 52-week high of $161.00 to $22.14, suggesting a speculative bubble burst. Despite a strong current ratio and zero debt, the lack of earnings and poor deterministic scores make the current valuation unsustainable.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
BMNR vs JPM: Head-to-Head Comparison
This page compares Bitmine Immersion Technologies, Inc. (BMNR) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.